These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6714413)

  • 1. QSAR in a series of muscarinic agents. Note V. New sets of rigid and flexible ligands.
    Pratesi P; Villa L; Ferri V; De Micheli C; De Amici M; Grana E; Santagostino Barbone MG; Silipo C; Vittoria A; Cappello B
    Farmaco Sci; 1984 Mar; 39(3):171-88. PubMed ID: 6714413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OSAR in a series of muscarinic agents. Note III--Alkyltrimethylammonium salts, ethers and esters of choline.
    Pratesi P; Villa L; Ferri V; De Micheli C; Grana E; Santagostino Barbone MG; Silipo C; Vittoria A
    Farmaco Sci; 1981 Sep; 36(9):749-64. PubMed ID: 7297670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR in a series of muscarinic agents. Note II - Pyridine and furan derivatives.
    Pratesi P; Villa L; Ferri V; de Micheli C; Grana E; Santagostino Barbone MG; Grieco C; Silipo C; Vittoria A
    Farmaco Sci; 1980 Aug; 35(8):621-35. PubMed ID: 7450050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR in a series of muscarinic agents. Note IV. - New pyridine and furan derivatives.
    Pratesi P; Villa L; Ferri V; De Micheli C; Grana E; Santagostino Barbone MG; Silipo C; Vittoria A
    Farmaco Sci; 1982 Jun; 37(6):398-410. PubMed ID: 7117512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure-activity relationship in the series of muscarinic acetylcholine receptor agonists: three types of agonist-receptor complexes].
    Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS
    Bioorg Khim; 1985 Oct; 11(10):1391-401. PubMed ID: 4074399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and muscarinic activity of some muscarone analogs.
    De Micheli C; De Amici M; Grana E; Zonta F; Giannella M; Piergentili A
    Farmaco; 1993 Oct; 48(10):1333-48. PubMed ID: 8117377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR in a series of muscarinic agents.
    Pratesi P; Villa L; Ferri V; De Micheli C; Grana E; Grieco C; Silipo C; Vittoria A
    Farmaco Sci; 1979 Aug; 34(8):657-65. PubMed ID: 467632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR in a series of muscarinic agents. Note VI. Five-membered cyclic ligands.
    Pratesi P; Grana E; Santagostino Barbone MG; La Rotonda MI; Silipo C; Vittoria A
    Farmaco Sci; 1986 May; 41(5):336-45. PubMed ID: 3720943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and stereochemical requirements for muscarinic receptor binding.
    Aronstam RS; Triggle DJ; Eldefrawi ME
    Mol Pharmacol; 1979 Mar; 15(2):227-34. PubMed ID: 470929
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative potencies of the stereoisomers of bethanechol on muscarinic receptor.
    De Micheli C; De Amici M; Pratesi P; Grana E; Santagostino Barbone MG
    Farmaco Sci; 1983 Jul; 38(7):514-20. PubMed ID: 6137411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent activity of 5-methylfurmethide at muscarinic receptors.
    Ochillo RF
    Arch Int Pharmacodyn Ther; 1980 Nov; 248(1):69-75. PubMed ID: 7212878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
    Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-activity relationships in a set of antimuscarinic agents.
    Cappello B; Silipo C; Vittoria A; Pratesi P
    Farmaco Sci; 1984 Dec; 39(12):991-1007. PubMed ID: 6529988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the contractile responses and their coupling second messenger systems for muscarinic drugs in the guinea-pig ileal longitudinal muscle.
    Konno F; Takayanagi I
    Arch Int Pharmacodyn Ther; 1989; 301():15-29. PubMed ID: 2624513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular requirements of the active sites of the cholinergic receptors. XIX-Size evaluation of the muscarinic subsite.
    Gualtieri F; Brasili L; Giannella M; Pigini M
    Farmaco Sci; 1982 Sep; 37(9):618-26. PubMed ID: 7128816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of parameters in QuaSAR studies of narcotic analgesics and antagonists.
    Katz R; Osborne S; Ionescu F; Andrulis P; Bates R; Beavers W; Chou PC; Loew G; Berkowitz D
    NIDA Res Monogr; 1978; (22):441-63. PubMed ID: 30912
    [No Abstract]   [Full Text] [Related]  

  • 17. [Structure-activity relationship in the series of muscarinic acetylcholine receptor antagonists: four types of antagonist-receptor binding].
    Tropsha AE; Nizhniĭ SV; Iaguzhinskiĭ LS
    Bioorg Khim; 1985 Oct; 11(10):1402-16. PubMed ID: 4074400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.
    Weinstein H; Green JP; Osman R; Edwards WD
    NIDA Res Monogr; 1978; (22):333-58. PubMed ID: 101884
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and muscarinic activity of the chiral forms of methylenemuscarones.
    De Amici M; De Micheli C; Gianferrara T; Grana E; Dondi G; Ladinsky H; Schiavi G
    Farmaco; 1993 Oct; 48(10):1349-57. PubMed ID: 8117378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A theoretical and experimental study of the semirigid cholinergic agonist 3-acetoxyquinuclidine.
    Weinstein H; Maayani S; Srebrenik S; Cohen S; Sokolovsky M
    Mol Pharmacol; 1975 Sep; 11(5):671-89. PubMed ID: 1177874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.